Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarction

Ma,Yi; Li,Li; Shang,Xiao-Ming; Tan,Zheng; Geng,Xue-Bin; Zhao,Bi-Qiong; Tian,Mei-Rong

doi:10.3892/etm.2013.927

Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarction

Authors:
- Yi Ma
- Li Li
- Xiao-Ming Shang
- Zheng Tan
- Xue-Bin Geng
- Bi-Qiong Zhao
- Mei-Rong Tian
View Affiliations

Affiliations: Department of Cardiovascular Medicine, The Tangshan Affiliated Clinical Hospital of Hebei Medical University, Tangshan, Hebei 063000, P.R. China
Published online on: January 25, 2013 https://doi.org/10.3892/etm.2013.927
Pages: 1206-1210

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the factors related to short-term prognosis in patients undergoing direct percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI). A total of 805 patients were included and divided into a control group and an adverse cardiovascular events group based on the prognosis, to compare risk factors and coronary angiographic characteristics in the two groups. In the adverse events group, the ages, admission blood glucose, uric acid (UA), homocysteine (HCY), creatine kinase (CK) and peak creatine kinase-MB (CKMB) isozyme levels were clearly higher compared with those in the control group, while the levels of total cholesterol (TC), triglycerides (TGs) and low-density lipoprotein (LDL) were lower compared with those in the control group. The incidence of hypertension in females in the adverse events group was markedly higher compared with that in the control group, while the diabetes rate was lower compared with that in the control group. Logistic regression analysis revealed that age, gender, hypertension, diabetes and admission blood glucose, HCY, TC and UA levels were independent risk factors of short-term prognosis in patients undergoing emergency PCI. The majority of the patients in the adverse events group were elderly females with hypertension, a large area of myocardial infarction and increased admission blood glucose, UA and HCY levels, as well as a low diabetes rate and decreased levels of acute-phase TC and LDL.

View Figures

View References

1	Ruiz-Bailén M, Aguayo de Hoyos E, Ramos-Cuadra JA, et al: Influence of age on clinical course, management and mortality of acute myocardial infarction in the Spanish population. Int J Cardiol. 85:285–296. 2002.PubMed/NCBI
2	Polewczyk A, Janion M, Gasior M, et al: Benefits from revascularisation therapy in the elderly with acute myocardial infarction. Comparative analysis of patients hospitalised in 1992–1996 and in 2005–2006. Kardiol Pol. 68:873–881. 2010.PubMed/NCBI
3	De Luca G, Suryapranata H, Dambrink JH, et al: Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study. Am Heart J. 148:852–856. 2004.
4	Griffith D, Hamilton K, Norrie J and Isles C: Early and late mortality after myocardial infarction in men and women: prospective observational study. Heart. 91:305–307. 2005. View Article : Google Scholar : PubMed/NCBI
5	Bickel C, Rupprecht HJ, Blankenberg S, et al: Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol. 89:12–17. 2002. View Article : Google Scholar : PubMed/NCBI
6	Short RA, Johnson RT and Tuttle KR: Uric acid, microalbuminuria and cardiovasular events in high-risk patients. Am J Nephrol. 25:36–64. 2005. View Article : Google Scholar : PubMed/NCBI
7	Car S and Trkulja V: Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study. Croat Med J. 50:559–566. 2009. View Article : Google Scholar : PubMed/NCBI
8	Washio T, Nomoto K, Watanabe I, et al: Relationship between plasma homocysteine levels and congestive heart failure in patients with acute myocardial infarction. Homocysteine and congestive heart failure. Int Heart J. 52:224–228. 2011. View Article : Google Scholar
9	Kadri Z, Danchin N, Vaur L, et al: Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study. Heart. 92:910–915. 2006.PubMed/NCBI
10	Coyal A, Mehta SR, Gerstein HC, et al: Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. Am Heart J. 157:763–770. 2009. View Article : Google Scholar : PubMed/NCBI
11	Ishihara M, Kojima S, Sakomoto T, et al: Comparison of blood glucose value on admission for acute myocardial infarction in patients with versus without diabetes mellitus. Am J Cardiol. 104:769–774. 2009. View Article : Google Scholar : PubMed/NCBI
12	Wahab NN, Cowden EA, Pearce NJ, et al: Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 40:1748–1754. 2002. View Article : Google Scholar : PubMed/NCBI
13	Ceriello A: Acute hyperglycaemia: a ‘new’ risk factor during myocardial infarction. Eur Heart J. 26:328–331. 2005.
14	Norhamraar A, Tenerz A, Nilsson G, et al: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes meullitus: a prospective study. Lancet. 359:2140–2l. 44:2002.PubMed/NCBI
15	Yan MZ, Hu Dy, Yu JM, et al: Newly diagnosed abnormal glucose tolerance in patients with acute coronary syndrome and without known diabetes mellitus. Zhonghua Yi Xue Za Zhi. 86:1256–1259. 2006.(In Chinese).
16	Gore JM, Goldberg RJ, Matsumoto AS, et al: Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol. 54:722–725. 1984. View Article : Google Scholar : PubMed/NCBI
17	Fyfe T, Baxter RH, Cochran KM, et al: Plasma-lipid changes after myocardial infarction. Lancet. 2:997–1001. 1971. View Article : Google Scholar : PubMed/NCBI
18	Kitsis RN and Jialal I: Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein. N Engl J Med. 355:513–515. 2006. View Article : Google Scholar : PubMed/NCBI
19	Gharacholou SM, Lopes RD, Alexander KP, et al: Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trial. Arch Intern Med. 171:559–567. 2011. View Article : Google Scholar
20	Kala P, Kanovsky J, Rokyta R, et al: Age-related treatment strategy and long-term outcome in acute myocardial infarction patients in the PCI era. BMC Cardiovasc Disord. 12:312012. View Article : Google Scholar : PubMed/NCBI
21	Tuomainen PO, Ylitalo A, Niemelä M, et al: Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial. J Invasive Cardiol. 24:104–108. 2012.PubMed/NCBI
22	Li Z, Li ZZ, Gao YL, et al: On-admission serum uric acid predicts outcomes after acute myocardial infarction: systematic review and meta-analysis of prognostic studies. Zhonghua Xin Xue Guan Bing Za Zhi. 40:225–230. 2012.(In Chinese).
23	Bae MH, Lee JH, Lee SH, et al: Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction. Circ J. 75:1440–1447. 2011. View Article : Google Scholar : PubMed/NCBI
24	Kim SY, Guevara JP, Kim KM, et al: Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 62:170–180. 2010.PubMed/NCBI